We live in a moment of profound disconnection from place, from each other, from our own interior lives. The systems we inhabit reward speed, efficiency, and scalability. They have very little use for depth, witness, or the slow work of meaning-making that human beings have always needed to survive what happens to them.

Narrative medicine and expressive writing are not merely clinical tools. They are acts of return. To the body. To the story. To the self. This is not a retreat from the modern world but a practice of remaining human while inside it.

For more than a decade, I have developed and taught curricula at the intersection of narrative medicine, expressive and trauma-informed writing protocols, and clinical practice, first in university classrooms, then in continuing education, and increasingly in hospitals, hospice organizations, and healthcare training environments.

My work is grounded in the original Pennebaker and Beall expressive writing paradigm, extended by a generation of scholars like Mihalcea, Seraj, and Boyd, who used computational linguistics to map expressive writing’s neurobiological effects at scale; Rude, whose work on emotion-acceptance instructions shows that how we hold the writing matters as much as whether we do it; and Memarian and Lieberman, whose neuroimaging research confirmed what Pennebaker’s behavioral data long suggested: that putting feeling into language changes the brain that holds it.

The 2023 JAMA Psychiatry non-inferiority trial, which found writing-based PTSD treatment comparable in efficacy to Prolonged Exposure therapy, is the culmination of this lineage, and the protocol that began with college students writing for twenty minutes in a laboratory is now in VA/DoD clinical practice guidelines.